EUVIMEDEUVIMED entdecken
Crossref

HIV rebound in HIV controllers is associated with a specific fecal microbiome profile

Yanhui Cai iD, Ondrej Podlaha, Steven G Deeks, Cynthia Brinson, Moti N Ramgopal, Edwin DeJesus, Anthony Mills, Peter Shalit, Mohamed Abdel-Mohsen, Liao Zhang iD, Christiaan R de Vries iD, Elena Vendrame iD und 2 weitere

European Journal of Immunology · 2024

DOI: 10.1002/eji.202350809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Yanhui Cai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences, Inc., Foster City, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Feces, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV infection is associated with gut dysbiosis, and microbiome variability may affect HIV control when antiretroviral therapy (ART) is stopped. The TLR7 agonist, vesatolimod, was previously associated with a modest delay in viral rebound following analytical treatment interruption in HIV controllers (HCs). Using a retrospective analysis of fecal samples from HCs treated with vesatolimod or placebo (NCT03060447), people with chronic HIV (CH; NCT02858401) or without HIV (PWOH), we examined fecal microbiome profile in HCs before/after treatment, and in CH and PWOH. Microbiome diversity and abundance were compared between groups to investigate the association between specific phyla/species, immune biomarkers, and viral outcomes during treatment interruption. Although there were no significant differences in gut microbiome diversity between people with and without HIV, HCs, and CH shared common features that distinguished them from PWOH. there was a trend toward greater microbiome diversity among HCs. Treatment with vesatolimod reduced dysbiosis in HCs. Firmicutes positively correlated with T‐cell activation, while Bacteroidetes and Euryarchaeota inversely correlated with TLR7‐mediated immune activation. Specific types of fecal microbiome abundance (e.g. Alistipes putredinis ) positively correlated with HIV rebound. In conclusion, variability in the composition of the fecal microbiome is associated with markers of immune activation following vesatolimod treatment and ART interruption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsFecesGastrointestinal MicrobiomeDysbiosisHumansMaleFemaleAdultMiddle AgedRetrospective StudiesViral LoadToll-Like Receptor 7HIV-1Pteridines

Stichwörter der Autor:innen

Fecal microbiomeHIV controllersHIV‐1 reboundImmune activationTLR7Vesatolimod

Substanzen

vesatolimodToll-Like Receptor 7TLR7 protein, humanPteridines

Autor:innen und Institutionen

  • Gilead Sciences, Inc., Foster City, California, USA.
  • Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Central Texas Clinical Research, Austin, Texas, USA.
  • Midway Immunology and Research Center, Fort Pierce, Florida, USA.
  • Orlando Immunology Centre, Orlando, Florida, USA.
  • Men's Health Foundation, West Hollywood, California, USA.

ORCID-Profile: Yanhui Cai, Liao Zhang, Christiaan R de Vries, Elena Vendrame, Jeffrey J Wallin

Förderung

  • Gilead Sciences

Zitieren

APA

Cai, Y., Podlaha, O., Deeks, S. G., Brinson, C., Ramgopal, M. N., DeJesus, E., Mills, A., Shalit, P., Abdel-Mohsen, M., Zhang, L., de Vries, C. R., Vendrame, E., SenGupta, D., & Wallin, J. J. (2024). HIV rebound in HIV controllers is associated with a specific fecal microbiome profile. European Journal of Immunology. https://doi.org/10.1002/eji.202350809

Vancouver

Cai Y, Podlaha O, Deeks SG, Brinson C, Ramgopal MN, DeJesus E, et al. HIV rebound in HIV controllers is associated with a specific fecal microbiome profile. European Journal of Immunology. 2024. doi:10.1002/eji.202350809

BibTeX
@article{Cai2024,
  author = {Cai, Yanhui and Podlaha, Ondrej and Deeks, Steven G and Brinson, Cynthia and Ramgopal, Moti N and DeJesus, Edwin and Mills, Anthony and Shalit, Peter and Abdel-Mohsen, Mohamed and Zhang, Liao and de Vries, Christiaan R and Vendrame, Elena and SenGupta, Devi and Wallin, Jeffrey J},
  title = {HIV rebound in HIV controllers is associated with a specific fecal microbiome profile},
  journal = {European Journal of Immunology},
  year = {2024},
  doi = {10.1002/eji.202350809}
}
Kostenlos starten →